A. Magnan (Nantes, France), L. Bjermer (Lund, Sweden)
Assesment of long-term omalizumab treatment in severe allergic asthma
E.S. Özgür, C. Özge, A. Ilvan, S. Atis Nayci (Mersin, Turkey)
|   |
Omalizumab improves lung function in severe persistent allergic (IgE-mediated) asthma patients: Pooled data from 5 UK centres
M. Masoli, B. Castell, D. Halpin, C. Chamberlain, R. Stone, R. Shrimanker, L. Dobson, K. Cutland, J. Suntharalingam, R. Carver, I. Kasujee (Plymouth, Exeter, Taunton, Torbay, Bath, Frimley/Camberley, United Kingdom)
| |
Long-term effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Real-life data from 3 UK centres
M. Britton, T. Howes, D. Saralaya, D. Hepburn, M. Nordstrom, K. Welham, K. Regan, I. Kasujee (Chertsey, Colchester, Bradford, Frimley/Camberley, United Kingdom)
| |
Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Pooled data from 4 UK centres
M. Britton, T. Howes, D. Saralaya, M. Masoli, M. Nordstrom, K. Regan, D. Hepburn, K. Welham, I. Kasujee (Chertsey, Colchester, Bradford, Plymouth, Frimley/Camberley, United Kingdom)
| |
Efficacy and safety of omalizumab in real-life practice in India
A. Mahashur, D. Talwar, M. Kotnis (Mumbai, Noida, India)
| |
Natural history of IgE sensitisation to food allergens in a cohort of adults
A. Patelis, C. Janson, A. Malinovschi, M. Gunnbjörnsdottir, T. Gislason, K. Torén, B. Forsberg (Uppsala, Gothenburg, Umeå, Sweden; Reykjavik, Iceland; London, United Kingdom)
| |
Analysis of IL-6 function in transmaternal asthma protection induced by Acinetobacter Iwoffii
D.A. Kesper, O. Pinkenburg, P.I. Pfefferle, H. Garn, H. Renz (Marburg, Germany)
| |
Allergyprotective effects of Staphylococcus scuiri in a house dust mite (HDM) model of allergic airway inflammation
S. Hagner, M. Zhao, H. Harb, H. Renz, P. Pfefferle, H. Garn (Marburg, Germany)
| |
Balance disturbances in asthmatic patients. An unrecognized link between lung, brain and labyrinth
A.G.J. Cunha, M.D.P.T. Nunes, R.M. Carvalho-Pinto, F.D.C. Martins, C.C. Boffino (Sao Paulo, Terezopolis, Brazil)
| |
Is serum cholesterol a risk factor for asthma?
S. Krishnamurthy, A.M. Kaza, K. Ramaraju, N. Balasubramanian, M. Smirthi (Coimbatore, India)
| |
Climate change: The impact of different pollen burden on hay fever peculiarities
R. Rozenson, S. Zhumambayeva (Astana, Kazakhstan)
| |
Association between body mass index and asthma, rhinitis and eczema in Chinese school children
N. Song, M. Shamssain, J. Zhang, S. Hao, J. Guan, J. Wu, C. Fu, X. Yan (Shijiazhuang, China; Sunderland, United Kingdom)
| |
Prevalence and severity of asthma, rhinitis and eczema in Chinese school children
N. Song, J. Zhang, M. Shamssain, S. Hao, J. Wu, C. Fu, X. Yan (Shijiazhuang, China; Sunderland, United Kingdom)
| |
Time changes in allergic rhinitis in Skopje, the Republic of Macedonia
M. Kimovska, E. Vlaski, L. Seckova, K. Stavric, R. Isjanovska (Skopje, Fyrom)
| |
Impact of adult rhinosinusitis on asthma severity
M. Bashir, B. Haman, N. Gariani, M. Shabani (Tripoli, Libyan Arab Jamahiriya)
| |
Association between pet ownership and asthma, rhinitis and eczema in Chinese schoolchildren
N. Song, M. Shamssain, J. Zhang, S. Hao, J. Guan, J. Wu, C. Fu, X. Yan (Shijiazhuang, China; Sunderland, United Kingdom)
| |
Anti-IgE antibodies inhibit the expression of amphiregulin in mast cells and suppress remodeling
M. Mizuguchi, M. Wada, K. Kikuchi, K. Akasaka, K. Kohyama, N. Fueki, H. Sagara (Koshigaya, Japan)
| |